2017International Journal of Dermatology and VenereologyRequires access

Cephalosporin and azithromycin resistance in Neisseria gonorrhoeae

Hongye Liu, Yan Han, Shao-Chun Chen

Open publisher page 1 citations

Abstract

Decreased susceptibility and resistance to first-line antibiotics have emerged in Neisseria gonorrhoeae worldwide, and resistance to broad-spectrum cephalosporins and azithromycin has raised special concerns. There have been many reports about high-level resistance to broad-spectrum cephalosporins and azithromycin in many regions, which raises alarms about combination therapy of gonorrhea. Mechanisms of drug resistance in Neisseria gonorrhoeae are extremely complex, mainly involving alterations in target sites of antibiotics, as well as decreased influx and increased efflux of antibiotics. These mechanisms depend on or synergize with each other to some extents. In-depth exploration into drug resistance in Neisseria gonorrhoeae may contribute to rational use of antibiotics in clinic and delay in the process of drug resistance. Key words: Neisseria gonorrhoeae; Gonorrhea; Cephalosporins; Drug resistance; Azithromycin

About this research paper

What this paper is about

Decreased susceptibility and resistance to first-line antibiotics have emerged in Neisseria gonorrhoeae worldwide, and resistance to broad-spectrum cephalosporins and azithromycin has raised special concerns. There have been many reports about high-level resistance to broad-spectrum cephalosporins and azithromycin in many regions, which raises alarms about combination therapy of gonorrhea. Mechanisms of drug resistance in Neisseria gonorrhoeae are extremely complex, mainly involving alterations in target sites of antibiotics, as well as decreased influx and increased efflux of antibiotics. These mechanisms depend on or synergize with each other to some extents. In-depth exploration into drug resistance in Neisseria gonorrhoeae may contribute to rational use of antibiotics in clinic and delay in the process of drug resistance. Key words: Neisseria gonorrhoeae; Gonorrhea; Cephalosporins; Drug resistance; Azithromycin

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Decreased susceptibility and resistance to first-line antibiotics have emerged in Neisseria gonorrhoeae worldwide, and resistance to broad-spectrum cephalosporins and azithromycin has raised special concerns. There have been many reports about high-level resistance to broad-spectrum cephalosporins and azithromycin in many regions, which raises alarms about combination therapy of gonorrhea. Mechanisms of drug resistance in Neisseria gonorrhoeae are extremely complex, mainly involving alterations in target sites of antibiotics, as well as decreased influx and increased efflux of antibiotics. These mechanisms depend on or synergize with each other to some extents. In-depth exploration into drug resistance in Neisseria gonorrhoeae may contribute to rational use of antibiotics in clinic and delay in the process of drug resistance. Key words: Neisseria gonorrhoeae; Gonorrhea; Cephalosporins; Drug resistance; Azithromycin

Key concepts: Neisseria gonorrhoeae, Azithromycin, Gonorrhea, Cephalosporin, Antibiotics, Microbiology, Antibiotic resistance, Drug resistance

Related papers

Back to paper searchBrowse research topicsOriginal source
Cephalosporin and azithromycin resistance in Neisseria gonorrhoeae — Research Paper | ScholarLens